Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)
CAPS Rating:
A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.
RSS Headlines
Fool UK
Recs
IDIX has a too high valuation compared to its sales potential. It is also loss making.